Aortic & peripheral arterial disease

10 trials
  • 2023BASIL-2RevascularisationIn 345 patients with chronic limb-threatening ischaemia requiring infra-popliteal revascularisation, a vein-bypass-first strategy worsened amputation-free survival compared with a best-endovascular-treatment-first strategy.
  • 2022BEST-CLIRevascularisationIn 1,830 patients with chronic limb-threatening ischaemia and infra-inguinal disease, surgical bypass reduced major adverse limb events or death compared with endovascular therapy, but only in those with an adequate single-segment great saphenous vein.
  • 2021ACST-2Carotid diseaseIn 3,625 asymptomatic patients with severe carotid stenosis, carotid artery stenting produced similar rates of procedural death or disabling stroke and 5-year non-procedural stroke compared with carotid endarterectomy.
  • 2020VOYAGER PADAntithrombotic therapyIn 6,564 patients with peripheral artery disease after lower-extremity revascularisation, rivaroxaban 2.5 mg twice daily plus aspirin reduced acute limb ischaemia, major amputation, myocardial infarction, ischaemic stroke or cardiovascular death compared with aspirin alone.
  • 2017EUCLIDAntithrombotic therapyIn 13,885 patients with symptomatic peripheral artery disease, ticagrelor monotherapy did not reduce cardiovascular death, myocardial infarction or ischaemic stroke compared with clopidogrel monotherapy.
  • 2016EVAR-1Aortic aneurysmIn 1,252 patients with a large asymptomatic abdominal aortic aneurysm fit for either procedure, endovascular aneurysm repair gave an early survival benefit but inferior late all-cause and aneurysm-related mortality compared with open surgical repair.
  • 2014IMPROVEAortic aneurysmIn 613 patients with a clinical diagnosis of ruptured abdominal aortic aneurysm, an endovascular-first strategy did not reduce 30-day mortality compared with emergency open repair.
  • 2013INSTEAD-XLAortic dissectionIn 140 patients with stable uncomplicated type B aortic dissection, thoracic endovascular aortic repair added to optimal medical therapy reduced 5-year aorta-specific mortality and disease progression compared with optimal medical therapy alone.
  • 2010CRESTCarotid diseaseIn 2,502 patients with symptomatic or asymptomatic carotid stenosis, carotid-artery stenting did not differ from carotid endarterectomy for periprocedural stroke, myocardial infarction or death, or subsequent ipsilateral stroke at 4 years.
  • 1998UK Small Aneurysm TrialAortic aneurysmIn 1,090 patients aged 60–76 years with a symptomless abdominal aortic aneurysm of 4.0–5.5 cm, early elective open repair did not reduce long-term all-cause mortality compared with ultrasonographic surveillance.